NovoCure Ltd - Ordinary Shares, no par value per share (NVCR)

CUSIP: G6674U108

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Ordinary Shares, no par value per share
Shares outstanding
112,245,592
Total 13F shares
95,516,854
Share change
+4,485,114
Total reported value
$1,235,376,652
Put/Call ratio
35%
Price per share
$12.93
Number of holders
237
Value change
+$58,055,560
Number of buys
141
Number of sells
100

Quarterly Holders Quick Answers

What is CUSIP G6674U108?
CUSIP G6674U108 identifies NVCR - NovoCure Ltd - Ordinary Shares, no par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NovoCure Ltd - Ordinary Shares, no par value per share (NVCR) as of Q4 2025

As of 31 Dec 2025, NovoCure Ltd - Ordinary Shares, no par value per share (NVCR) was held by 237 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 95,516,854 shares. The largest 10 holders included FMR LLC, BlackRock, Inc., VANGUARD GROUP INC, Soleus Capital Management, L.P., MORGAN STANLEY, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, Quantinno Capital Management LP, RENAISSANCE TECHNOLOGIES LLC, and Palo Alto Investors LP. This page lists 237 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.